Insmed (NASDAQ:INSM) Price Target Raised to $96.00
Insmed (NASDAQ:INSM – Free Report) had its target price raised by Bank of America from $92.00 to $96.00 in a research note issued to investors on Thursday morning,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. A number of other research analysts also recently issued reports on the company. Wells Fargo […]
Insmed (NASDAQ:INSM – Free Report) had its target price raised by Bank of America from $92.00 to $96.00 in a research note issued to investors on Thursday morning,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. A number of other research analysts also recently issued reports on the company. Wells Fargo […]
